Patent · US Active

Transdermal delivery rate control using amorphous pharmaceutical compositions

US8357393B2 · kind B2 · utility

6Cited by
28References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 7, 2004
Grant dateJan 22, 2013
Priority date
Expiry dateNov 30, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P33/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical composition for transdermal delivery comprising

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.